multivalent filovirus vaccine (NewLink/Merck & Co)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemultivalent filovirus vaccine (NewLink/Merck & Co)
Drug Alias Namemultivalent filovirus vaccine (PHAC)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsFiloviridae InfectionsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPublic Health Agency Of Canada
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLumos Pharma IncMerck & Co IncPublic Health Agency Of Canada
Active IndicationsN/A
Inactive IndicationsFiloviridae InfectionsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A